

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | acrosome assembly (GO:0001675) | 6.31166203 |
| 2 | cellular extravasation (GO:0045123) | 5.96100713 |
| 3 | negative regulation of Rho protein signal transduction (GO:0035024) | 5.50068434 |
| 4 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 5.04623028 |
| 5 | auditory receptor cell differentiation (GO:0042491) | 4.85838458 |
| 6 | Notch signaling involved in heart development (GO:0061314) | 4.29912496 |
| 7 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 4.15574685 |
| 8 | neural tube formation (GO:0001841) | 4.11432206 |
| 9 | RNA destabilization (GO:0050779) | 4.07226971 |
| 10 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 4.06766101 |
| 11 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.92378812 |
| 12 | prostate gland growth (GO:0060736) | 3.84903115 |
| 13 | cardiac right ventricle morphogenesis (GO:0003215) | 3.83501357 |
| 14 | intraciliary transport (GO:0042073) | 3.72492228 |
| 15 | DNA integration (GO:0015074) | 3.62402737 |
| 16 | response to pheromone (GO:0019236) | 3.57280689 |
| 17 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.51180235 |
| 18 | nucleotide transmembrane transport (GO:1901679) | 3.49912622 |
| 19 | DNA double-strand break processing (GO:0000729) | 3.47518144 |
| 20 | protein targeting to lysosome (GO:0006622) | 3.42399326 |
| 21 | establishment of protein localization to vacuole (GO:0072666) | 3.42399326 |
| 22 | protein targeting to vacuole (GO:0006623) | 3.42399326 |
| 23 | platelet dense granule organization (GO:0060155) | 3.41732860 |
| 24 | anterograde synaptic vesicle transport (GO:0048490) | 3.35586724 |
| 25 | mitochondrion distribution (GO:0048311) | 3.33026152 |
| 26 | protein localization to Golgi apparatus (GO:0034067) | 3.32937858 |
| 27 | phosphatidylinositol dephosphorylation (GO:0046856) | 3.31616708 |
| 28 | protein targeting to Golgi (GO:0000042) | 3.31166067 |
| 29 | regulation of sarcomere organization (GO:0060297) | 3.25624986 |
| 30 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.24963493 |
| 31 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 3.23844071 |
| 32 | wound healing, spreading of epidermal cells (GO:0035313) | 3.22089382 |
| 33 | phospholipid dephosphorylation (GO:0046839) | 3.20847754 |
| 34 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.20118819 |
| 35 | establishment of protein localization to Golgi (GO:0072600) | 3.18369462 |
| 36 | membrane budding (GO:0006900) | 3.16056009 |
| 37 | male meiosis (GO:0007140) | 3.11207925 |
| 38 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.09681192 |
| 39 | hair cell differentiation (GO:0035315) | 3.09104994 |
| 40 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.02021157 |
| 41 | sequestering of actin monomers (GO:0042989) | 3.00454603 |
| 42 | regulation of DNA damage checkpoint (GO:2000001) | 3.00054081 |
| 43 | C-terminal protein lipidation (GO:0006501) | 2.97310342 |
| 44 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.97262898 |
| 45 | regulation of development, heterochronic (GO:0040034) | 2.91541703 |
| 46 | C-terminal protein amino acid modification (GO:0018410) | 2.89974576 |
| 47 | positive regulation of phosphatase activity (GO:0010922) | 2.89427880 |
| 48 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.88522439 |
| 49 | regulation of timing of cell differentiation (GO:0048505) | 2.86876571 |
| 50 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.86715985 |
| 51 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.86154495 |
| 52 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.84696069 |
| 53 | acrosome reaction (GO:0007340) | 2.83774969 |
| 54 | renal tubule development (GO:0061326) | 2.79980557 |
| 55 | positive regulation of macroautophagy (GO:0016239) | 2.76559698 |
| 56 | chondrocyte proliferation (GO:0035988) | 2.75737451 |
| 57 | regulation of glucokinase activity (GO:0033131) | 2.74337220 |
| 58 | regulation of hexokinase activity (GO:1903299) | 2.74337220 |
| 59 | glycolipid biosynthetic process (GO:0009247) | 2.73852477 |
| 60 | osteoclast differentiation (GO:0030316) | 2.71207417 |
| 61 | protein localization to cilium (GO:0061512) | 2.70364780 |
| 62 | rRNA methylation (GO:0031167) | 2.69586335 |
| 63 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.69025638 |
| 64 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.69025638 |
| 65 | glycosphingolipid biosynthetic process (GO:0006688) | 2.67792934 |
| 66 | secondary heart field specification (GO:0003139) | 2.67569058 |
| 67 | heart field specification (GO:0003128) | 2.67569058 |
| 68 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.66337650 |
| 69 | negative regulation of stress fiber assembly (GO:0051497) | 2.65038608 |
| 70 | phagocytosis, recognition (GO:0006910) | 2.63747344 |
| 71 | carnitine metabolic process (GO:0009437) | 2.62488615 |
| 72 | specification of organ identity (GO:0010092) | 2.59200140 |
| 73 | mitochondrial DNA replication (GO:0006264) | 2.55662923 |
| 74 | cardiac cell development (GO:0055006) | 2.54861512 |
| 75 | positive regulation of mitochondrial fission (GO:0090141) | 2.54219386 |
| 76 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 2.53945969 |
| 77 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 2.53945969 |
| 78 | ether lipid metabolic process (GO:0046485) | 2.53624773 |
| 79 | protein K11-linked deubiquitination (GO:0035871) | 2.53196939 |
| 80 | nephron tubule development (GO:0072080) | 2.53178027 |
| 81 | neuronal stem cell maintenance (GO:0097150) | 2.52152680 |
| 82 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.49254442 |
| 83 | protein localization to lysosome (GO:0061462) | 2.49233446 |
| 84 | protein localization to vacuole (GO:0072665) | 2.49233446 |
| 85 | positive regulation of mast cell degranulation (GO:0043306) | 2.48925357 |
| 86 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.48925357 |
| 87 | regulation of alkaline phosphatase activity (GO:0010692) | 2.44847017 |
| 88 | GPI anchor metabolic process (GO:0006505) | 2.44346036 |
| 89 | lipid particle organization (GO:0034389) | 2.43658777 |
| 90 | peptidyl-cysteine modification (GO:0018198) | 2.38926192 |
| 91 | pericardium development (GO:0060039) | 2.38498324 |
| 92 | myoblast differentiation (GO:0045445) | 2.38282542 |
| 93 | positive regulation of dephosphorylation (GO:0035306) | 2.37263798 |
| 94 | regulation of hippo signaling (GO:0035330) | 2.34639755 |
| 95 | neuron fate determination (GO:0048664) | 2.33452005 |
| 96 | cilium morphogenesis (GO:0060271) | 2.30216845 |
| 97 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.29233846 |
| 98 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.29233846 |
| 99 | cellular response to fluid shear stress (GO:0071498) | 2.27604525 |
| 100 | piRNA metabolic process (GO:0034587) | 2.27211118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 3.51810085 |
| 2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.24060453 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.19236502 |
| 4 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.92875353 |
| 5 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.84601999 |
| 6 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.84514004 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.80537238 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.67527696 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.66696086 |
| 10 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.56496608 |
| 11 | FUS_26573619_Chip-Seq_HEK293_Human | 2.53102234 |
| 12 | EWS_26573619_Chip-Seq_HEK293_Human | 2.36997405 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.34682183 |
| 14 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.24150698 |
| 15 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.20215124 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.13983358 |
| 17 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.06777487 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 2.02291022 |
| 19 | P300_19829295_ChIP-Seq_ESCs_Human | 2.01060460 |
| 20 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.00413940 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.97134285 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.94055228 |
| 23 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.88752997 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.85259507 |
| 25 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.82025134 |
| 26 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.80438349 |
| 27 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.78338955 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.73854973 |
| 29 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.71928353 |
| 30 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.71814276 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.62671528 |
| 32 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.60742053 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.59233570 |
| 34 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.58912144 |
| 35 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.58912144 |
| 36 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.58096740 |
| 37 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.54660466 |
| 38 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.54019087 |
| 39 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.53377454 |
| 40 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.49415509 |
| 41 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.49311358 |
| 42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.46879056 |
| 43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43392339 |
| 44 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.42443346 |
| 45 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.41890142 |
| 46 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.41435094 |
| 47 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.40862592 |
| 48 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.40862592 |
| 49 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40851633 |
| 50 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.39385307 |
| 51 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.34496930 |
| 52 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.32878806 |
| 53 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.32356112 |
| 54 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.30922560 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28836237 |
| 56 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.28182286 |
| 57 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.27627764 |
| 58 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.27492091 |
| 59 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.26943628 |
| 60 | CJUN_26792858_Chip-Seq_BT549_Human | 1.25446737 |
| 61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.25319076 |
| 62 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.22123938 |
| 63 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.21675374 |
| 64 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.20177913 |
| 65 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19979299 |
| 66 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.19183560 |
| 67 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17520519 |
| 68 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.17296526 |
| 69 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.16743041 |
| 70 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.15484198 |
| 71 | KDM2B_26808549_Chip-Seq_REH_Human | 1.15443035 |
| 72 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15250906 |
| 73 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.14450292 |
| 74 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.14319410 |
| 75 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.11492366 |
| 76 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.10155118 |
| 77 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.09722532 |
| 78 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.07895516 |
| 79 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06996370 |
| 80 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.05121215 |
| 81 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04451687 |
| 82 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04285597 |
| 83 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03541034 |
| 84 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03028279 |
| 85 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.02945360 |
| 86 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.02686455 |
| 87 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02538922 |
| 88 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00252015 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99914240 |
| 90 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98555429 |
| 91 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98555429 |
| 92 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.98435545 |
| 93 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.96534662 |
| 94 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.96463599 |
| 95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96270658 |
| 96 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.95376946 |
| 97 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95033988 |
| 98 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92557283 |
| 99 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.92315747 |
| 100 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.92125840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.39955066 |
| 2 | MP0006054_spinal_hemorrhage | 3.95490852 |
| 3 | MP0008789_abnormal_olfactory_epithelium | 3.43934284 |
| 4 | MP0005075_abnormal_melanosome_morpholog | 3.37252770 |
| 5 | MP0003195_calcinosis | 2.90574231 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 2.84686624 |
| 7 | MP0005408_hypopigmentation | 2.79863960 |
| 8 | MP0005394_taste/olfaction_phenotype | 2.77044920 |
| 9 | MP0005499_abnormal_olfactory_system | 2.77044920 |
| 10 | MP0002234_abnormal_pharynx_morphology | 2.59475016 |
| 11 | MP0000751_myopathy | 2.33578410 |
| 12 | MP0003656_abnormal_erythrocyte_physiolo | 2.29749393 |
| 13 | MP0003122_maternal_imprinting | 2.27832663 |
| 14 | MP0003252_abnormal_bile_duct | 2.22774476 |
| 15 | MP0001661_extended_life_span | 2.21550151 |
| 16 | MP0003121_genomic_imprinting | 2.20224364 |
| 17 | MP0003646_muscle_fatigue | 2.14543169 |
| 18 | MP0004233_abnormal_muscle_weight | 2.06612429 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.02704047 |
| 20 | MP0000015_abnormal_ear_pigmentation | 2.00557046 |
| 21 | MP0004147_increased_porphyrin_level | 1.92211568 |
| 22 | MP0002928_abnormal_bile_duct | 1.88870181 |
| 23 | MP0003221_abnormal_cardiomyocyte_apopto | 1.84710272 |
| 24 | MP0008877_abnormal_DNA_methylation | 1.81752078 |
| 25 | MP0005084_abnormal_gallbladder_morpholo | 1.79304145 |
| 26 | MP0000749_muscle_degeneration | 1.73660049 |
| 27 | MP0000516_abnormal_urinary_system | 1.73296193 |
| 28 | MP0005367_renal/urinary_system_phenotyp | 1.73296193 |
| 29 | MP0000371_diluted_coat_color | 1.65210135 |
| 30 | MP0002090_abnormal_vision | 1.62775313 |
| 31 | MP0002108_abnormal_muscle_morphology | 1.60471800 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.54897381 |
| 33 | MP0005248_abnormal_Harderian_gland | 1.53620334 |
| 34 | MP0000767_abnormal_smooth_muscle | 1.52893612 |
| 35 | MP0005085_abnormal_gallbladder_physiolo | 1.52228036 |
| 36 | MP0002295_abnormal_pulmonary_circulatio | 1.51842525 |
| 37 | MP0005220_abnormal_exocrine_pancreas | 1.44902402 |
| 38 | MP0002938_white_spotting | 1.42995878 |
| 39 | MP0010678_abnormal_skin_adnexa | 1.42117747 |
| 40 | MP0005197_abnormal_uvea_morphology | 1.40627332 |
| 41 | MP0002095_abnormal_skin_pigmentation | 1.38722776 |
| 42 | MP0001984_abnormal_olfaction | 1.38045293 |
| 43 | MP0000013_abnormal_adipose_tissue | 1.37963675 |
| 44 | MP0004133_heterotaxia | 1.36564392 |
| 45 | MP0002102_abnormal_ear_morphology | 1.34731130 |
| 46 | MP0002163_abnormal_gland_morphology | 1.28538516 |
| 47 | MP0002006_tumorigenesis | 1.27898246 |
| 48 | MP0004215_abnormal_myocardial_fiber | 1.27335167 |
| 49 | MP0002233_abnormal_nose_morphology | 1.20425469 |
| 50 | MP0006292_abnormal_olfactory_placode | 1.18136231 |
| 51 | MP0003724_increased_susceptibility_to | 1.15798304 |
| 52 | MP0000427_abnormal_hair_cycle | 1.14094300 |
| 53 | MP0001542_abnormal_bone_strength | 1.12586392 |
| 54 | MP0009046_muscle_twitch | 1.12236540 |
| 55 | MP0001324_abnormal_eye_pigmentation | 1.11849850 |
| 56 | MP0002751_abnormal_autonomic_nervous | 1.08905839 |
| 57 | MP0005171_absent_coat_pigmentation | 1.07152137 |
| 58 | MP0002075_abnormal_coat/hair_pigmentati | 1.04326698 |
| 59 | MP0003950_abnormal_plasma_membrane | 1.03567558 |
| 60 | MP0002269_muscular_atrophy | 1.02763278 |
| 61 | MP0001529_abnormal_vocalization | 1.02004245 |
| 62 | MP0003279_aneurysm | 1.01278373 |
| 63 | MP0002166_altered_tumor_susceptibility | 1.00455720 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 0.99488255 |
| 65 | MP0000372_irregular_coat_pigmentation | 0.99365765 |
| 66 | MP0001186_pigmentation_phenotype | 0.98896105 |
| 67 | MP0003787_abnormal_imprinting | 0.95880758 |
| 68 | MP0009703_decreased_birth_body | 0.89958412 |
| 69 | MP0003385_abnormal_body_wall | 0.83309798 |
| 70 | MP0005253_abnormal_eye_physiology | 0.81970070 |
| 71 | MP0002177_abnormal_outer_ear | 0.79607322 |
| 72 | MP0001293_anophthalmia | 0.79528939 |
| 73 | MP0002127_abnormal_cardiovascular_syste | 0.77707164 |
| 74 | MP0004142_abnormal_muscle_tone | 0.75534749 |
| 75 | MP0003755_abnormal_palate_morphology | 0.75450595 |
| 76 | MP0001915_intracranial_hemorrhage | 0.74352308 |
| 77 | MP0003172_abnormal_lysosome_physiology | 0.73326759 |
| 78 | MP0000750_abnormal_muscle_regeneration | 0.72127092 |
| 79 | MP0004484_altered_response_of | 0.71071736 |
| 80 | MP0000383_abnormal_hair_follicle | 0.70594130 |
| 81 | MP0003937_abnormal_limbs/digits/tail_de | 0.68301880 |
| 82 | MP0001929_abnormal_gametogenesis | 0.66763168 |
| 83 | MP0002160_abnormal_reproductive_system | 0.65558715 |
| 84 | MP0006072_abnormal_retinal_apoptosis | 0.63480224 |
| 85 | MP0005391_vision/eye_phenotype | 0.63305132 |
| 86 | MP0002092_abnormal_eye_morphology | 0.61420855 |
| 87 | MP0005620_abnormal_muscle_contractility | 0.61313660 |
| 88 | MP0005332_abnormal_amino_acid | 0.61078243 |
| 89 | MP0004085_abnormal_heartbeat | 0.59950569 |
| 90 | MP0000653_abnormal_sex_gland | 0.59924579 |
| 91 | MP0002653_abnormal_ependyma_morphology | 0.57911602 |
| 92 | MP0008260_abnormal_autophagy | 0.57244408 |
| 93 | MP0008438_abnormal_cutaneous_collagen | 0.57232524 |
| 94 | MP0010386_abnormal_urinary_bladder | 0.55092240 |
| 95 | MP0005369_muscle_phenotype | 0.54800413 |
| 96 | MP0002971_abnormal_brown_adipose | 0.54703874 |
| 97 | MP0001145_abnormal_male_reproductive | 0.53762730 |
| 98 | MP0004036_abnormal_muscle_relaxation | 0.51259058 |
| 99 | MP0003566_abnormal_cell_adhesion | 0.49984447 |
| 100 | MP0002254_reproductive_system_inflammat | 0.49917758 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papillary thyroid carcinoma (HP:0002895) | 4.56907194 |
| 2 | Metaphyseal dysplasia (HP:0100255) | 4.47774377 |
| 3 | Amyotrophic lateral sclerosis (HP:0007354) | 4.15296344 |
| 4 | Thyroid carcinoma (HP:0002890) | 3.99784712 |
| 5 | Fair hair (HP:0002286) | 3.87377465 |
| 6 | Neonatal respiratory distress (HP:0002643) | 3.49335324 |
| 7 | Genital tract atresia (HP:0001827) | 3.48879006 |
| 8 | Hypothermia (HP:0002045) | 3.42534204 |
| 9 | Vertebral arch anomaly (HP:0008438) | 3.38070820 |
| 10 | Degeneration of anterior horn cells (HP:0002398) | 3.34316492 |
| 11 | Abnormality of the anterior horn cell (HP:0006802) | 3.34316492 |
| 12 | Medial flaring of the eyebrow (HP:0010747) | 3.26994332 |
| 13 | Biliary tract neoplasm (HP:0100574) | 3.21015665 |
| 14 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 3.17561087 |
| 15 | Congenital primary aphakia (HP:0007707) | 3.11468535 |
| 16 | Gait imbalance (HP:0002141) | 3.08059455 |
| 17 | Nephrogenic diabetes insipidus (HP:0009806) | 3.05229706 |
| 18 | Short tibia (HP:0005736) | 3.04465443 |
| 19 | Pulmonary artery stenosis (HP:0004415) | 3.02764483 |
| 20 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 3.02649656 |
| 21 | Generalized hypopigmentation of hair (HP:0011358) | 3.02565003 |
| 22 | Bifid tongue (HP:0010297) | 2.87191205 |
| 23 | Hematochezia (HP:0002573) | 2.84073439 |
| 24 | Chorioretinal atrophy (HP:0000533) | 2.80196994 |
| 25 | Dyskinesia (HP:0100660) | 2.76952803 |
| 26 | Microglossia (HP:0000171) | 2.68373922 |
| 27 | Tubulointerstitial nephritis (HP:0001970) | 2.63617733 |
| 28 | Abnormal biliary tract morphology (HP:0012440) | 2.60792146 |
| 29 | Drooling (HP:0002307) | 2.53131220 |
| 30 | Vaginal atresia (HP:0000148) | 2.52618646 |
| 31 | Febrile seizures (HP:0002373) | 2.52292555 |
| 32 | Type I diabetes mellitus (HP:0100651) | 2.50811005 |
| 33 | Anterior segment dysgenesis (HP:0007700) | 2.47523957 |
| 34 | Median cleft lip (HP:0000161) | 2.45774766 |
| 35 | Albinism (HP:0001022) | 2.44773929 |
| 36 | Hip dysplasia (HP:0001385) | 2.43756207 |
| 37 | Excessive salivation (HP:0003781) | 2.38946496 |
| 38 | Absent speech (HP:0001344) | 2.34664688 |
| 39 | Atonic seizures (HP:0010819) | 2.34029113 |
| 40 | Long nose (HP:0003189) | 2.32379377 |
| 41 | Inappropriate behavior (HP:0000719) | 2.31696943 |
| 42 | Abnormality of proline metabolism (HP:0010907) | 2.27782493 |
| 43 | Hydroxyprolinuria (HP:0003080) | 2.27782493 |
| 44 | Upper motor neuron abnormality (HP:0002127) | 2.27333707 |
| 45 | Exotropia (HP:0000577) | 2.26941290 |
| 46 | Limb-girdle muscle weakness (HP:0003325) | 2.25673321 |
| 47 | Abnormality of the renal medulla (HP:0100957) | 2.25348665 |
| 48 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.25029140 |
| 49 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.25029140 |
| 50 | Cone-rod dystrophy (HP:0000548) | 2.16185831 |
| 51 | Tented upper lip vermilion (HP:0010804) | 2.14950234 |
| 52 | Abnormality of the metopic suture (HP:0005556) | 2.08830814 |
| 53 | Prolonged neonatal jaundice (HP:0006579) | 2.06699877 |
| 54 | Disinhibition (HP:0000734) | 2.06665731 |
| 55 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.06546709 |
| 56 | Poor coordination (HP:0002370) | 2.06111175 |
| 57 | Rimmed vacuoles (HP:0003805) | 2.05266718 |
| 58 | Exocrine pancreatic insufficiency (HP:0001738) | 2.04931749 |
| 59 | Polyphagia (HP:0002591) | 2.03021665 |
| 60 | Broad alveolar ridges (HP:0000187) | 2.02174029 |
| 61 | Tubulointerstitial abnormality (HP:0001969) | 2.01272322 |
| 62 | Mutism (HP:0002300) | 2.01272029 |
| 63 | Pancreatic fibrosis (HP:0100732) | 1.99450395 |
| 64 | Postaxial hand polydactyly (HP:0001162) | 1.97322183 |
| 65 | Methylmalonic acidemia (HP:0002912) | 1.96912378 |
| 66 | Cutaneous melanoma (HP:0012056) | 1.96141439 |
| 67 | Vascular calcification (HP:0004934) | 1.95548610 |
| 68 | Abnormality of the calf musculature (HP:0001430) | 1.94049377 |
| 69 | Cardiovascular calcification (HP:0011915) | 1.92260820 |
| 70 | Widely spaced teeth (HP:0000687) | 1.88447731 |
| 71 | Generalized hypopigmentation (HP:0007513) | 1.88321278 |
| 72 | Abnormality of the lower motor neuron (HP:0002366) | 1.87594158 |
| 73 | Tetraparesis (HP:0002273) | 1.87118861 |
| 74 | Ketoacidosis (HP:0001993) | 1.84327088 |
| 75 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.84322524 |
| 76 | Molar tooth sign on MRI (HP:0002419) | 1.84184223 |
| 77 | Abnormality of midbrain morphology (HP:0002418) | 1.84184223 |
| 78 | Broad-based gait (HP:0002136) | 1.83544241 |
| 79 | Abnormality of vitamin B metabolism (HP:0004340) | 1.83470915 |
| 80 | Hyperventilation (HP:0002883) | 1.83052545 |
| 81 | Specific learning disability (HP:0001328) | 1.81847418 |
| 82 | Blue irides (HP:0000635) | 1.81278066 |
| 83 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.80803371 |
| 84 | Prominent metopic ridge (HP:0005487) | 1.79220226 |
| 85 | Mitral stenosis (HP:0001718) | 1.78877109 |
| 86 | Shoulder girdle muscle weakness (HP:0003547) | 1.77621797 |
| 87 | Entropion (HP:0000621) | 1.77340601 |
| 88 | Type II lissencephaly (HP:0007260) | 1.77297382 |
| 89 | Gowers sign (HP:0003391) | 1.76778606 |
| 90 | Ulnar claw (HP:0001178) | 1.75215116 |
| 91 | Abnormality of salivation (HP:0100755) | 1.75072132 |
| 92 | Astigmatism (HP:0000483) | 1.74432420 |
| 93 | Ovarian neoplasm (HP:0100615) | 1.73420763 |
| 94 | Pachygyria (HP:0001302) | 1.71421273 |
| 95 | Abnormal neuron morphology (HP:0012757) | 1.71273778 |
| 96 | Abnormality of the motor neurons (HP:0002450) | 1.71273778 |
| 97 | Chronic hepatic failure (HP:0100626) | 1.71192888 |
| 98 | Neoplasm of the rectum (HP:0100743) | 1.70349756 |
| 99 | Gonadotropin excess (HP:0000837) | 1.68018470 |
| 100 | Nephronophthisis (HP:0000090) | 1.67044615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.46373861 |
| 2 | TAF1 | 4.39405183 |
| 3 | ERBB3 | 4.07526348 |
| 4 | MAP4K2 | 3.53636558 |
| 5 | BCR | 3.42837531 |
| 6 | SIK3 | 2.49945691 |
| 7 | NTRK1 | 2.49216487 |
| 8 | TRIM28 | 2.47074315 |
| 9 | DYRK3 | 2.22978773 |
| 10 | MAP3K4 | 2.18499870 |
| 11 | CDK19 | 2.06768221 |
| 12 | WNK3 | 1.95453022 |
| 13 | STK38L | 1.93179428 |
| 14 | NTRK2 | 1.82757969 |
| 15 | TNIK | 1.81247160 |
| 16 | SRPK1 | 1.66754783 |
| 17 | MAP2K7 | 1.65484383 |
| 18 | STK24 | 1.57731854 |
| 19 | EIF2AK3 | 1.57695319 |
| 20 | FGFR2 | 1.51448456 |
| 21 | KSR1 | 1.51031248 |
| 22 | BRD4 | 1.50198019 |
| 23 | GRK1 | 1.46222598 |
| 24 | OXSR1 | 1.45647588 |
| 25 | CAMKK2 | 1.38410286 |
| 26 | PAK3 | 1.34905888 |
| 27 | EPHA3 | 1.32985567 |
| 28 | PLK2 | 1.32458694 |
| 29 | TGFBR2 | 1.28079520 |
| 30 | MAPK13 | 1.25060120 |
| 31 | CSNK1G3 | 1.24128863 |
| 32 | BMPR1B | 1.18333588 |
| 33 | CSNK1G1 | 1.15086991 |
| 34 | CSNK1G2 | 1.13201935 |
| 35 | NEK9 | 1.12823081 |
| 36 | BRSK2 | 1.10123791 |
| 37 | ACVR1B | 1.08545248 |
| 38 | ZAP70 | 1.02364084 |
| 39 | RPS6KA4 | 1.01847775 |
| 40 | PIK3CG | 1.00732369 |
| 41 | PRKCE | 0.99512279 |
| 42 | MAPK7 | 0.99085305 |
| 43 | MAP3K12 | 0.98721850 |
| 44 | STK39 | 0.96270652 |
| 45 | PRKD3 | 0.94022203 |
| 46 | PTK2B | 0.91603154 |
| 47 | EPHA4 | 0.91166452 |
| 48 | MAP3K2 | 0.90360849 |
| 49 | ADRBK2 | 0.89718904 |
| 50 | NUAK1 | 0.86349906 |
| 51 | MYLK | 0.79957374 |
| 52 | PINK1 | 0.79953052 |
| 53 | MKNK1 | 0.79072014 |
| 54 | MKNK2 | 0.77427005 |
| 55 | STK11 | 0.77396698 |
| 56 | CCNB1 | 0.75404292 |
| 57 | BMPR2 | 0.71902194 |
| 58 | LIMK1 | 0.71415638 |
| 59 | DYRK1B | 0.71037307 |
| 60 | INSRR | 0.70260642 |
| 61 | CDK9 | 0.68494541 |
| 62 | CSNK1A1L | 0.68209814 |
| 63 | JAK2 | 0.67445174 |
| 64 | PRKD1 | 0.65199278 |
| 65 | MAP2K4 | 0.62247943 |
| 66 | OBSCN | 0.61752733 |
| 67 | KSR2 | 0.61332906 |
| 68 | EGFR | 0.56297344 |
| 69 | NTRK3 | 0.56135896 |
| 70 | CDK6 | 0.55835979 |
| 71 | FER | 0.55323513 |
| 72 | CASK | 0.52961566 |
| 73 | IKBKB | 0.51014297 |
| 74 | IKBKE | 0.50577202 |
| 75 | MAPK12 | 0.46875911 |
| 76 | GRK7 | 0.46644387 |
| 77 | PRKAA1 | 0.45490536 |
| 78 | TGFBR1 | 0.43355103 |
| 79 | AKT3 | 0.41220244 |
| 80 | STK3 | 0.40784344 |
| 81 | IRAK1 | 0.40596664 |
| 82 | TYK2 | 0.39728175 |
| 83 | STK38 | 0.37751340 |
| 84 | FGFR3 | 0.37216689 |
| 85 | PIK3CA | 0.37039801 |
| 86 | TAOK3 | 0.32204386 |
| 87 | GRK5 | 0.30951538 |
| 88 | PRKD2 | 0.29008130 |
| 89 | RAF1 | 0.28697499 |
| 90 | MAP3K1 | 0.27071637 |
| 91 | VRK1 | 0.25803068 |
| 92 | FGR | 0.24685133 |
| 93 | CAMK2A | 0.24373240 |
| 94 | PRKAA2 | 0.24260597 |
| 95 | MST4 | 0.24165733 |
| 96 | CSNK1A1 | 0.23918675 |
| 97 | PDGFRA | 0.23628664 |
| 98 | ABL1 | 0.23456227 |
| 99 | GSK3A | 0.23094128 |
| 100 | PRKG1 | 0.22989487 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.32224823 |
| 2 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.30220133 |
| 3 | Basal transcription factors_Homo sapiens_hsa03022 | 2.66374365 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.63870359 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.61094821 |
| 6 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.31257131 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.30442136 |
| 8 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.25250493 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.22869963 |
| 10 | Circadian rhythm_Homo sapiens_hsa04710 | 2.13889393 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.12630867 |
| 12 | ABC transporters_Homo sapiens_hsa02010 | 2.04983713 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.97756526 |
| 14 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.76767706 |
| 15 | Lysine degradation_Homo sapiens_hsa00310 | 1.75292066 |
| 16 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.61155673 |
| 17 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.60827420 |
| 18 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.60521766 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.52883359 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.49670244 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.45823090 |
| 22 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.45503450 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.43067382 |
| 24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.39591694 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.30276403 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30161901 |
| 27 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.27594117 |
| 28 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.25934690 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.23716914 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.23317791 |
| 31 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.23250012 |
| 32 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.20541282 |
| 33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.17596753 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.15006436 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12995521 |
| 36 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.12212972 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.08865687 |
| 38 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.06318512 |
| 39 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.01819444 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01420795 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00955927 |
| 42 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99354049 |
| 43 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.97800226 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97294904 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96932543 |
| 46 | RNA degradation_Homo sapiens_hsa03018 | 0.89382518 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.87876365 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.86730083 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86694267 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.86432229 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84935171 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84149070 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80210798 |
| 54 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.80043065 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78948392 |
| 56 | Prostate cancer_Homo sapiens_hsa05215 | 0.78833488 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76413951 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.74391158 |
| 59 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.74140852 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 0.72901006 |
| 61 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.67693083 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.65768404 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.65401566 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59351721 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58532612 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57188883 |
| 67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56082491 |
| 68 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55222167 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54210823 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.49112767 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48668252 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.46068001 |
| 73 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.45359803 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43647158 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42340812 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41796866 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41462682 |
| 78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40563001 |
| 79 | Glioma_Homo sapiens_hsa05214 | 0.40145611 |
| 80 | Adherens junction_Homo sapiens_hsa04520 | 0.39093076 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36429506 |
| 82 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.35995252 |
| 83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35600244 |
| 84 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.34562867 |
| 85 | Renin secretion_Homo sapiens_hsa04924 | 0.33413066 |
| 86 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.33269298 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31608609 |
| 88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31439417 |
| 89 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.31348233 |
| 90 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.29655751 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.29506373 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29219550 |
| 93 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.28341377 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27501914 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25905295 |
| 96 | Focal adhesion_Homo sapiens_hsa04510 | 0.25803372 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.25145031 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23391464 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.22583449 |
| 100 | Olfactory transduction_Homo sapiens_hsa04740 | 0.21283836 |

